Federal Register · Regulatory notice
Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 34 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Follow LLY- Became public
- Jul 6, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 7:38 PM EST
Why this is connected
The source explicitly mentions ELI LILLY & Co. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
ayed-Release Way, Deerfield, IL Tablets, EQ 20 mg 60015. base; 375 mg, and EQ 20 mg base; 500 mg. NDA 050467.............. Doxorubicin Pfizer Inc., 66 Hudson Hydrochloride Blvd. East, New York, (doxorubicin HCl) NY 10001. Injectable, 10 mg/ vial, 20 mg/vial, 50 mg/vial, and 150 mg/ vial. NDA 201194.............. Oxycodone VistaPharm, LLC, 20 Hydrocholoride Waterview Blvd., (oxycodone HCl) Suite 303, Solution, 5 mg/5 mL. Parsippany, NJ 07054. NDA 202020.............. Rayos (prednisone) Horizon Therapeutics Delayed-Release USA, Inc., 1 Horizon Tablets, 1 mg, 2 mg, Way, Deerfield, IL and 5 mg. 60015. NDA 204623.............. Pennsaid (diclofenac Horizon Therapeutics sodium) Solution, 2%. Ireland DAC c/o Horizon Therapeutics USA, Inc., 1 Horizon Way, Deerfield, IL 60015. NDA 204803.............. Posimir (bupivacaine) Innocoll Solution, 660 mg/5 mL Pharmaceuticals (132 mg/mL). Limited c/o Allucent, 2000 Centregreen Way, Suite 300, Cary, NC 27513. NDA 206030.............. Carnexiv Lundbeck (carbamazepine) Pharmaceuticals LLC, Solution, 200 mg/20 6 Pkwy. North, Suite mL (10 mg/mL). 400, Deerfield, IL 60015. NDA 209128.............. Dsuvia (sufentanil Vertical citrate) Tablet, EQ Pharmaceuticals, LLC, 0.03 mg base. 1880 McFarland Pkwy., Suite 110B, Alpharetta, GA 30005. NDA 209511.............. Xaracoll (bupivacaine Innocoll HCl) Implant, 100 mg. Pharmaceuticals Limited c/o Allucent, 2
Congressional trading in LLY
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Jul 1, 2026 · disclosed Aug 7, 2026
Committee overlap: Energy and CommerceGot $1K from the company’s PAC - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Jan 2, 2026 · disclosed Aug 7, 2026 · filed 217 days later
Committee overlap: Energy and CommerceGot $1K from the company’s PAC - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Dec 2, 2025 · disclosed Aug 7, 2026 · filed 248 days later
Committee overlap: Energy and CommerceGot $1K from the company’s PAC - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Sold (full) Eli Lilly and Company LLY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
- Jul 2, 2026$50K–$100K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Eli Lilly and Company LLY
$50K–$100K · Traded Jun 10, 2026 · disclosed Jul 2, 2026
- May 13, 2026$1K–$15K
Rep. Byron Donalds (R-FL-19)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Apr 2, 2026 · disclosed May 13, 2026
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.